PIK3CA and breast cancer: These findings show that increased PI3K activity mediated by two copies of myr-p110α, when combined with either p53fl/fl or p53fl/fl;KrasG12D, have the potential to skew mammary tumors from a sarcomatoid phenotype to a carcinoma phenotype more common in humans.